Human Fas/TNFRSF6/CD95 Antibody
Human Fas/TNFRSF6/CD95 Antibody Summary
Applications
under non-reducing conditions only
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Fas/TNFRSF6/CD95
Fas, also known as APO-1, CD95, and TNFRSF6, was originally identified as a cell-surface protein which binds to monoclonal antibodies that were cytolytic for various human cell lines. In the TNF Receptor superfamily nomenclature, Fas is referred to as TNFRSF6. Human Fas cDNA encodes a 325 amino acid (aa) residue type 1 membrane protein that belongs to the TNF and NGF receptor family. Alternatively spliced cDNAs encoding multiple Fas isoforms, including a soluble form of Fas lacking the transmembrane domain, have also been identified. Fas is highly expressed in epithelial cells, hepatocytes, activated mature lymphocytes, virus-transformed lymphocytes, and other tumor cells. Fas expression has also been detected in mouse thymus, liver, heart, lung, kidney, and ovary. The ligand for Fas (FasL) has been identified and shown to be a member of the TNF family of type 2 membrane proteins. FasL is predominantly expressed by activated T‑lymphocytes, NK cells, and in tissues with immune-privileged sites. Soluble FasL can be produced by proteolysis of membrane-associated Fas.
Ligation of Fas by FasL or anti-Fas antibody has been shown to induce apoptotic cell death in Fas-bearing cells. Fas plays a role in the down-regulation of the immune reaction and has been shown to be a key mediator of activation-induced death of activated T lymphocytes. Fas-mediated cell death has also been shown to be important for the deletion of activated or autoreactive B lymphocytes. Besides the perforin/granzyme-based mechanism, the Fas system has been identified as the alternate pathway for CTL-mediated cytotoxicity. FasL has also been shown to function in immunological privileged sites by killing infiltrating Fas-bearing lymphocytes and inflammatory cells.
- Nagata, S. and P. Golstein (1995) Science 267:1449.
- Nagata, S. (1997) Cell 88:355.
- Parijs, L. and A.K. Abbas (1996) Current Opinion in Immunol. 8:355.
- Green, D.R. and C.F. Ware (1997) Proc. Natl. Acad. Sci. USA 94:5986.
Product Datasheets
Citations for Human Fas/TNFRSF6/CD95 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
6
Citations: Showing 1 - 6
Filter your results:
Filter by:
-
CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism
Authors: Johannes Nelke, Juliane Medler, Daniela Weisenberger, Andreas Beilhack, Harald Wajant
mAbs
-
Human cytomegalovirus suppresses Fas expression and function
Authors: Sepehr Seirafian, Virginie Prod’homme, Daniel Sugrue, James Davies, Ceri Fielding, Peter Tomasec et al.
Journal of General Virology
-
Invasive trophoblasts stimulate vascular smooth muscle cell apoptosis by a fas ligand-dependent mechanism.
Authors: Harris LK, Keogh RJ, Wareing M, Baker PN, Cartwright JE, Aplin JD, Whitley GS
Am. J. Pathol., 2006-11-01;169(5):1863-74.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-Fr -
Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
Authors: Chopin V, Slomianny C, Hondermarck H, Le Bourhis X
Exp. Cell Res., 2004-08-15;298(2):560-73.
Species: Human
Sample Types: Whole Cells
Applications: Functional Assay -
Ceramide induces a loss in cytosolic peroxide levels in mononuclear cells.
Authors: Phillips DC, Griffiths HR
Biochem. J., 2003-11-01;375(0):567-79.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas.
Authors: Savarese TM, Campbell CL, McQuain C, Mitchell K, Guardiani R, Quesenberry PJ, Nelson BE
Cytokine, 2002-03-21;17(6):324-34.
Species: Human
Sample Types: Whole Cells
Applications: Functional Assay
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human Fas/TNFRSF6/CD95 Antibody
Average Rating: 5 (Based on 1 Review)
Have you used Human Fas/TNFRSF6/CD95 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by: